Adverse effect of plasma exchange on anti-D production in rhesus immunisation owing to removal of inhibitory factors.-Reference-Cited by-同舟云学术

Adverse effect of plasma exchange on anti-D production in rhesus immunisation owing to removal of inhibitory factors.

Published:1980-06-28 Issue:6231 Volume:280 Page:1569-1571
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Barclay G R,Greiss M A,Urbaniak S J

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference12 articles.

1. Intensive plasmapheresis as a therapeutic measure in rhesus-immunised women;Clarke, C.A.; Elson, C.J.; Bradley, J.; Donohoe, W.T.A.; Lehane, D.; Hughes-Jones, N.C.;Lancet,1970

2. Intensive antenatal plasmapheresis in severe rhesus isoimmunisation;Fraser, I.D.; Bothamley, J.E.; Bennet, M.O.;Lancet,1976

3. Intense plasmapheresis in the pregnant Rh-sensitized woman;LC, Jr, Powell;Am Jf Obstet Gynecol,1968

4. Continuous-flow exchangeplasmapheresis in severe rhesus isoimmunisation;Graham-Pole, JR, Barr; W, Willoughby; M.L.N.;Lancet,1974

5. Manipulative and inherent errors in anti-D quantitation using the AutoAnalyzer;Gunson, H.H.; Phillips, P.K.; Stratton, F.;J Clin Pathol,1972

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04

2. Current perspective and scope of fetal therapy: part 2;The Journal of Maternal-Fetal & Neonatal Medicine;2020-11-01

3. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue;Journal of Clinical Apheresis;2019-06

4. Management of red blood cell alloimmunization in pregnancy;Journal of Gynecology Obstetrics and Human Reproduction;2018-05

5. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn – review on current management and outcome;Expert Review of Hematology;2017-03-20